Marina Rousseau

449 total citations
15 papers, 341 citations indexed

About

Marina Rousseau is a scholar working on Nephrology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Marina Rousseau has authored 15 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 3 papers in Molecular Biology and 3 papers in Clinical Biochemistry. Recurrent topics in Marina Rousseau's work include Renal Diseases and Glomerulopathies (5 papers), Chronic Kidney Disease and Diabetes (4 papers) and Metabolism and Genetic Disorders (3 papers). Marina Rousseau is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Chronic Kidney Disease and Diabetes (4 papers) and Metabolism and Genetic Disorders (3 papers). Marina Rousseau collaborates with scholars based in France, Canada and United States. Marina Rousseau's co-authors include François Mion, Y Minaire, Pedro Geraldes, Jean-Louis Brazier, J. L. Brazier, Farah Lizotte, P Paliard, Rita Labroo, Kent L. Kunze and F. Lepage and has published in prestigious journals such as Diabetes, Gut and Scientific Reports.

In The Last Decade

Marina Rousseau

15 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marina Rousseau France	11	79	79	58	57	53	15	341
Trinidad Parra Spain	8	44 0.6×	89 1.1×	54 0.9×	24 0.4×	27 0.5×	10	391
Ken Thummel United States	6	23 0.3×	125 1.6×	25 0.4×	27 0.5×	22 0.4×	10	337
Rachel Sayer United Kingdom	5	58 0.7×	143 1.8×	21 0.4×	14 0.2×	107 2.0×	5	447
Yi‐Hung Kuo Taiwan	10	78 1.0×	88 1.1×	70 1.2×	46 0.8×	21 0.4×	19	360
A Bartorelli Italy	11	53 0.7×	179 2.3×	23 0.4×	27 0.5×	26 0.5×	35	568
A. Şükrü Aynacıoğlu Türkiye	12	25 0.3×	112 1.4×	14 0.2×	14 0.2×	37 0.7×	16	377
Jochen Ludwig Germany	9	62 0.8×	184 2.3×	32 0.6×	7 0.1×	58 1.1×	11	493
O Hansson Sweden	9	16 0.2×	62 0.8×	36 0.6×	48 0.8×	66 1.2×	23	360
G. Hedenborg Sweden	11	104 1.3×	54 0.7×	90 1.6×	6 0.1×	32 0.6×	32	360
José Manuel González de Buitrago Spain	8	78 1.0×	68 0.9×	31 0.5×	6 0.1×	22 0.4×	28	301

Countries citing papers authored by Marina Rousseau

Since Specialization

Citations

This map shows the geographic impact of Marina Rousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Rousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Rousseau more than expected).

Fields of papers citing papers by Marina Rousseau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Rousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Rousseau. The network helps show where Marina Rousseau may publish in the future.

Co-authorship network of co-authors of Marina Rousseau

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Rousseau. A scholar is included among the top collaborators of Marina Rousseau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Rousseau. Marina Rousseau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lizotte, Farah, Marina Rousseau, Dominique Lévesque, et al.. (2023). Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease. Kidney International. 104(4). 787–802. 16 indexed citations

Lizotte, Farah, Marina Rousseau, Sarah Higgins, et al.. (2022). Enhanced SHP-1 Expression in Podocyturia Is Associated with Kidney Dysfunction in Patients with Diabetes. Kidney360. 3(10). 1710–1719. 3 indexed citations

Rousseau, Marina, et al.. (2022). Reduction of DUSP4 contributes to podocytes oxidative stress, insulin resistance and diabetic nephropathy. Biochemical and Biophysical Research Communications. 624. 127–133. 9 indexed citations

Rousseau, Marina, et al.. (2021). Growth Factor Deregulation and Emerging Role of Phosphatases in Diabetic Peripheral Artery Disease. Frontiers in Cardiovascular Medicine. 7. 619612–619612. 12 indexed citations

Rousseau, Marina, et al.. (2020). Saturated fatty acids induce insulin resistance in podocytes through inhibition of IRS1 via activation of both IKKβ and mTORC1. Scientific Reports. 10(1). 21628–21628. 21 indexed citations

Rousseau, Marina, et al.. (2019). Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy. Diabetes. 68(5). 1026–1039. 38 indexed citations

Rousseau, Marina, et al.. (2016). Impact of Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer: A Prospective Evaluation at a Single Institution. Current Oncology. 23(1). 65–69. 11 indexed citations

Tran, Agnès, Elisabeth Rey, Gérard Pons, et al.. (1997). Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: In vitro and in vivo comparison and calculation of in vivo inhibition constants*. Clinical Pharmacology & Therapeutics. 62(5). 490–504. 89 indexed citations

Mion, François, et al.. (1997). 13C-Urea Breath Test for Helicobacter Pylori: Cut-off Point Determination by Cluster Analysis. Clinical Science. 93(1). 3–6. 40 indexed citations

10.

Mion, François, et al.. (1996). Continuous monitoring of 13C-aminopyrine metabolism in rats: Effects of cold exposure and noradrenaline. Life Sciences. 58(12). 1001–1008. 2 indexed citations

11.

Mion, François, et al.. (1996). Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.. PubMed. 42(6). 931–8. 41 indexed citations

12.

Mion, François, Marina Rousseau, Jean-Louis Brazier, & Y Minaire. (1995). Human hepatic macrovesicular steatosis: A noninvasive study of mitochondrial ketoisocaproic acid decarboxylation. Metabolism. 44(6). 699–700. 27 indexed citations

13.

Brazier, J. L., et al.. (1995). Theophylline pharmacokinetics and metabolism in rabbits following single and repeated administration ofCapsicum fruit. European Journal of Drug Metabolism and Pharmacokinetics. 20(3). 173–178. 12 indexed citations

14.

Mion, François, Alain Géloën, Marina Rousseau, Jean-Louis Brazier, & Y Minaire. (1994). Mechanism of carbon tetrachloride autoprotection: An in vivo study based on 13C-aminopyrine and 13C-galactose breath tests. Life Sciences. 54(26). 2093–2098. 18 indexed citations

15.

Mion, François, et al.. (1993). Liver - general. Gut. 34(3 Suppl). S43–S44. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact